January 2022 in “Revista del Centro Dermatológico Pascua” PRP therapy is a promising treatment for male hair loss on the vertex.
November 2025 in “Open Repository of the University of Porto (University of Porto)” Pharmacists play a crucial role in customizing treatments and ensuring medication safety.
April 2025 in “Revista de Ciências da Saúde Nova Esperança” Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.
October 2024 in “Revista Científica Dynamikos” A hair implant clinic in Bogotá is feasible and can offer affordable treatments for medium-income individuals.
3 citations
,
May 2020 in “Actas Dermo-Sifiliográficas” PRP injections increased hair density in men with hair loss but didn't work for everyone and more research is needed.
1 citations
,
October 2023 in “RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218” Alopecia androgenética in women can lower self-esteem and cause mental health issues.
1 citations
,
January 2024 in “Acta Bioclínica” Hair and scalp health needs more attention in medical training.
Personalized, multidisciplinary care improves skin condition management and patient outcomes.
August 2024 in “RCMOS - Revista Científica Multidisciplinar O Saber” Barbershops should prioritize safe, responsible scalp care and refer clients to dermatologists when needed.
May 2024 in “SPIRE - Sciences Po Institutional REpository” Understanding and treating alopecia areata improves patient care.
Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.
August 2023 in “Anales de la Facultad de Ciencias Médicas” The patient with lupus and hair loss improved with oral and topical minoxidil.
Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.
May 2018 in “Más dermatología” The higher dose supplement was more effective in treating female hair loss.
July 2014 in “Journal of the Portuguese Society of Dermatology and Venereology” Trichoscopy is useful for diagnosing and monitoring hair and scalp conditions.
2 citations
,
October 2020 in “Dermatologie pro praxi” Early diagnosis is crucial for treating alopecia effectively.
March 2023 in “Revista Chilena de Urología” Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.
10 citations
,
April 2018 in “Actas Dermo-Sifiliográficas” In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.
2 citations
,
November 2018 in “Medunab” Low ferritin levels are linked to chronic hair loss in women.
10 citations
,
January 2013 in “Actas Dermo-Sifiliográficas” Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.
November 2022 in “Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME)” The conditioner with Serenoa serrulata and tocoferol helps reduce hair loss.
Androgenetic alopecia is common in younger adults, especially with a family history.
May 2026 in “Revista fisio&terapia.” Combining treatments like minoxidil, microneedling, and platelet-rich plasma is more effective for hair loss than using them alone.
May 2025 in “RCMOS - Revista Científica Multidisciplinar O Saber” Combining different therapies is needed for effective male hair loss treatment.
October 2023 in “Recima21” Platelet-rich plasma treatment is effective for increasing hair thickness and works well for hair density in men with androgenetic alopecia.
The hair lotion from Ganoderma lucidum extract effectively promotes hair growth and reduces hair loss.
November 2025 in “Contribuciones a las Ciencias Sociales” Non-drug treatments improved hair growth and reduced hair loss in androgenetic alopecia.
July 2025 in “Actas Dermo-Sifiliográficas” Botulinum toxin A does not significantly improve hair density or thickness in androgenetic alopecia.
April 2022 in “Medicina estética” Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.
November 2024 in “Revista fisio&terapia.” JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.